Healthcare · Medical - Specialties
Price
$22.23
Market Cap
$79.2M
Employees
55
Beta
1.03
Avg Volume
261,979
CEO
Scott G. Davis
Business Description
Ekso Bionics Holdings, Inc., which began operations on January 30, 2012, and is headquartered in San Rafael, California, specializes in developing, refining, and marketing advanced exoskeleton technology. These innovative systems are currently applied in both the medical and industrial fields.
Business History
Price History (1 Year)
Deep Analysis
Pre-flight intelligence scans the company first, then routes to the right analytical methods.
0
Company Classification
— What type of company is this?
1
Industry Landscape
— Where is the industry headed?
2
Company Momentum
— Where is this company trending?
3
Forward Projection
— 1Y & 2Y projected metrics (requires Layer 1 + 2)
4a
DCF Valuation
— Present value of future cash flows
4b
Earnings Power Value
— Floor value — worth with zero growth
4c
Anchored PE
— Industry PE adjusted for growth differential
4d
Reverse DCF
— What growth is the market pricing in?
4e
Revenue-Based DCF
— For growth/narrative companies (skip if mature earner)
4f
Anchored P/S
— Price-to-Sales peer comparison (skip if mature earner)
4g
Scenario Analysis
— Bull / Base / Bear (skip if mature earner)
4h
Dividend Discount Model
— For dividend/income stocks only
4i
Book Value Analysis
— For deep value / turnaround stocks only
4j
Insider Activity
— Are insiders buying or selling?
4f
Cash Flow Quality
— How trustworthy is the FCF?
4g
Debt Maturity Risk
— Can it handle its debt?
4h
Macro Environment
— Rates, market valuation, volatility
4i
Sector Intelligence
— How does this company compare within its sector?
4j
Revenue Confidence
— How reliable is the growth projection?
4k
Sensitivity Analysis
— How fragile is the fair value estimate?
4l
Sector Demand Cycle
— Is the sector in a boom, steady state, or contraction?
5
AI Investigation
— Adaptive research engine (Claude)
5b
Thesis Evaluation
— What does the market believe? (narrative/platform stocks only)
6
Valuation Synthesis
— Weighted verdict from all methods (requires Layer 4)
Insider Trading (Recent)
Last updated: Jun 27, 2026 6:23am (2h ago)
Type codes
PPurchase
SSale
AAward / grant
MOption exercise
FIn-kind (tax)
CConversion
GGift
DReturn to issuer
All SEC Form 4 codes
Open market
- P Purchase
- Open-market or private purchase of shares.
- S Sale
- Open-market or private sale of shares.
Compensation (Rule 16b-3)
- A Award / grant
- Grant or award of securities (RSUs, options, etc.) under Rule 16b-3.
- D Return to issuer
- Securities disposed back to the company under Rule 16b-3.
- F In-kind (tax)
- Shares withheld or delivered to pay the option-exercise price or tax — not an open-market sale.
- I Discretionary
- Discretionary transaction under an employee plan — Rule 16b-3(f).
- M Option exercise
- Exercise or conversion of a derivative (option/RSU) into shares — exempt.
Derivatives
- C Conversion
- Conversion of a derivative security into the underlying shares.
- E Short expiration
- Expiration of a short derivative position.
- H Long expiration
- Expiration or cancellation of a long derivative position with value received.
- O OTM exercise
- Exercise of an out-of-the-money derivative.
- X ITM exercise
- Exercise of an in-the-money or at-the-money derivative.
Other exempt
- G Gift
- Bona fide gift of securities.
- L Small acquisition
- Small acquisition under Rule 16a-6.
- W Inheritance
- Acquisition or disposition by will or the laws of descent.
- Z Voting trust
- Deposit into or withdrawal from a voting trust.
Other
- J Other
- Other acquisition or disposition (explained in a Form 4 footnote).
- K Equity swap
- Transaction in an equity swap or similar instrument.
- U Tender / buyout
- Disposition via tender of shares in a change-of-control transaction.
Compensation-plan codes (A, D, F, M) are routine and rarely directional. Open-market P (buy) and S (sale) carry the most signal.
| Date | Insider | Type | Shares | Price | Value |
|---|---|---|---|---|---|
| 2026-05-14 | CLANCY WILLIAM M | A-Award | 200,000.00 | $0.00 | $0 |
| 2026-05-14 | Cummins Wes | A-Award | 200,000.00 | $0.00 | $0 |
| 2026-05-14 | Benson Ella G. | A-Award | 200,000.00 | $0.00 | $0 |
| 2026-05-14 | Nottenburg Richard N | A-Award | 200,000.00 | $0.00 | $0 |
| 2026-05-14 | Wong Jerome | A-Award | 40,000.00 | $0.00 | $0 |
| 2026-05-14 | MILLER DOUGLAS S | A-Award | 200,000.00 | $0.00 | $0 |
| 2026-05-14 | Davis Scott G. | A-Award | 109,357.00 | $0.00 | $0 |
| 2026-05-05 | Cummins Wes | 3,563,878.00 | $0.00 | $0 | |
| 2026-05-05 | MILLER DOUGLAS S | 0.00 | $0.00 | $0 | |
| 2026-05-05 | Applied Digital Corp. | 0.00 | $0.00 | $0 | |
| 2026-05-05 | Applied Digital Corp. | 0.00 | $0.00 | $0 | |
| 2026-05-05 | Benson Ella G. | 0.00 | $0.00 | $0 | |
| 2026-05-05 | CLANCY WILLIAM M | 0.00 | $0.00 | $0 | |
| 2026-05-05 | Nottenburg Richard N | 0.00 | $0.00 | $0 | |
| 2026-05-05 | Chen Ying Cenly | 0.00 | $0.00 | $0 |
Narrative Economics
The story the market is telling about this stock — the intangible X-factor
(founder mythology, cult dynamics, TAM-of-imagination) that moves price beyond
what cash flows alone explain. After Shiller, Narrative Economics.
No narrative profile yet for CHRN — it's generated by the pipeline (
market-narrative step).
No community reviews yet for CHRN.
Be the first — hit How to Contribute, have any AI review this page, and paste its take back here.
My Notes
personal — only you see this
Sign in to save personal notes and rate your interest in this stock.
Data via Financial Modeling Prep · Cached for performance · fmp
v1.1.352 · d1100787 · 2026-06-26 11:39:30